Search results
Alnylam Skyrockets After Hitting A 'Best-Case Scenario' For Heart Drug
Investor's Business Daily· 12 hours agoIn this disease, abnormal protein builds up on the heart and causes damage. Across all patients —...
Latest XBB COVID-19 vaccine offers protection against hospitalization, deaths
Center for Infectious Disease Research and Policy· 12 hours agoShare Copied to clipboard Today, JAMA Internal Medicine published a study calculating the protection...
Pfizer Inc. (NYSE:PFE) Shares Sold by B. Riley Wealth Advisors Inc.
ETF DAILY NEWS· 7 days agoB. Riley Wealth Advisors Inc. decreased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 15.0% during the fourth quarter, according to its most recent 13F ...
ProFound Therapeutics teams up with Pfizer to develop obesity treatments
BioPharma-Reporter· 7 days agoProFound Therapeutics has teamed up with Pfizer to develop obesity treatments. Under the terms of...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 3 days agoHere's why they picked AstraZeneca (NASDAQ: AZN), Bristol Myers Squibb (NYSE: BMY), and Pfizer (NYSE: PFE). AstraZeneca is a growth beast with loads of...
Ables Iannone Moore & Associates Inc. Purchases New Stake in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 7 days agoAbles Iannone Moore & Associates Inc. bought a new stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) during the 4th quarter, according to the company in its most recent ...
Alnylam reveals positive Phase III results for rare heart disease drug vutrisiran
Clinical Trials Arena via Yahoo Finance· 15 hours agoPatients in the experimental arm were administered 25mg subcutaneous vutrisiran at a three-month...
3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold
Motley Fool via Yahoo Finance· 3 days agoTheir stock prices may have been beaten down, but it's more than likely that better days are ahead....
3 No-Brainer Stocks to Buy for Under $100 Right Now
The Motley Fool via AOL· 3 days agoHere's why they picked AstraZeneca (NASDAQ: AZN), Bristol Myers Squibb (NYSE: BMY), and Pfizer (NYSE: PFE). AstraZeneca is a growth beast with loads of potential upside David ...
Want an Extra $100 in Annual Dividend Income? Invest $1,320 in These 3 High-Yield Stocks
The Motley Fool via AOL· 2 days agoInvestors who are attracted to truly passive income generation may want to consider AT&T (NYSE: T),...